title: How to approach endocrine assessment in severe obesity?
abstract: The increasing numbers of severely obese patients (body mass index BMI >40 kg/m(2) ) represent a significant management challenge. These patients are at risk of obesity-related complications that may be driven by changes in endocrine function. Their care may potentially be complex at times, and therefore, an appropriate assessment strategy will be relevant to timely diagnosis and management. In this article, we discuss an approach to the endocrine assessment of the severely obese patient. We consider the clinical question in three categories that may also represent different complexities in terms of subsequent management: (i) obesity as a consequence of structural lesions at the hypothalamic-pituitary region; (ii) obesity as a consequence of inherited and genetic syndromes; and (iii) functional neuroendocrine hormone abnormalities relating to obesity. The first two categories are associated with hypothalamic dysfunction, of which hypothalamic obesity is a consequence. Additionally, the implications and difficulties associated with imaging severely obese patients are discussed from an endocrinological perspective and we provide practical guidance on which to base practice.
authors.affiliation: Department of Obesity and Endocrinology, University of Liverpool, Clinical Sciences Centre, University Hospital Aintree, Liverpool, UK.
authors.forename: Ian W
authors.initials: IW
authors.lastname: Seetho
authors.forename: John P H
authors.initials: JP
authors.lastname: Wilding
mesh_terms: D006801:Humans; D007027:Hypothalamic Diseases / Q000175:diagnosis*; D009767:Obesity, Morbid / Q000150:complications*; D010900:Pituitary Diseases / Q000175:diagnosis*